hCG: The Peptide With Real Approvals and a Dead Claim

hCG is the most unusual entry in the peptide category, because almost everything about it inverts the normal pattern. Most compounds on this site are unapproved, untested, and sold on a mechanism. hCG is an approved medicine with decades of clinical use, a legitimate role in male fertility — and one of the most thoroughly disproven claims in the history of weight loss attached to it.

So the honest summary has two halves that point in opposite directions. For hypogonadotropic hypogonadism and for preserving fertility alongside testosterone therapy, hCG does something real and documented. For weight loss, it was tested in randomized, placebo-controlled trials four separate times in the 1970s and 1980s and failed every one. Those are not competing opinions about the same evidence. They are two different questions with two different answers.

One point of terminology before the detail: hCG is a glycoprotein hormone rather than a short peptide chain, so calling it a "peptide" stretches the word. It is grouped with peptides commercially because it is injected, sold on the same menus, and used by the same population — which is exactly the kind of category slippage we unpack in is Ozempic a peptide.

What hCG Actually Does

hCG mimics luteinizing hormone. In men it signals the testes directly, driving intratesticular testosterone production and supporting sperm production. That is the whole mechanism, and it is why its legitimate uses are what they are.

In male hypogonadotropic hypogonadism — where the signal from the pituitary is the problem rather than the testes themselves — gonadotropin therapy is an established treatment with documented benefits for spermatogenesis and fertility¹. There is real outcome literature here, including work on inducing spermatogenesis in men with prepubertal-onset hypogonadotropic hypogonadism and identifying who responds². This is medicine, prescribed for a diagnosis, with endpoints that were measured.

The Use That Matters Most to Readers of This Site

Here is where hCG becomes directly relevant to anyone weighing testosterone therapy, and it is the reason this compound belongs on a performance site at all.

Exogenous testosterone suppresses the body's own signal to the testes, and with it sperm production. That is not a rare side effect — it is the expected consequence, well described in the review literature on testosterone replacement and spermatogenesis in reproductive-age men³. Anyone starting TRT who might want children later is making a fertility decision at the same time, whether or not the prescriber frames it that way.

hCG is the standard answer. In a study of men undergoing testosterone replacement therapy, concomitant intramuscular hCG preserved spermatogenesis⁴. That is a specific, useful, clinically actionable finding, and it is the single most valuable thing on this page.

It is also why hCG shows up beside TRT on telehealth menus rather than beside the research peptides. LaSara prices TRT at $169 a month and gonadorelin at $99 either way — one-time or subscribed — on product pages that publish a one-time price, a subscription price and a per-day cost for everything they sell. The fertility question is exactly the sort of thing that should be raised before the first injection rather than after, and we build the argument out in full on best weight loss peptides for men, where whether one provider can manage both sides of that trade-off is the ranking criterion. Our best online TRT providers board covers what the monitored version costs.

For the adjacent compound sold on similar reasoning, see kisspeptin.

The Weight-Loss Claim, and Why It Is Genuinely Settled

The hCG diet has been sold since the 1950s, on the theory that hCG injections alongside a very-low-calorie diet cause preferential fat loss and suppress hunger. It is worth being precise about why this one is different from the usual "no trial has been run" finding on this site.

The trials were run. They are old, they are randomized, they are placebo-controlled, and there are several of them:

• •A double-blind crossover study in JAMA examined chorionic gonadotropin in weight control⁵.
• •A double-blind study in the American Journal of Clinical Nutrition was titled, without ambiguity, "Ineffectiveness of human chorionic gonadotropin in weight reduction"⁶.
• •A randomized clinical study in the Journal of Family Practice examined hCG in weight reduction⁷.
• •A double-blind, placebo-controlled trial in the South African Medical Journal tested hCG and weight loss again in 1990⁸.

Four independent randomized tests, across three decades and multiple countries. The weight loss on the hCG diet comes from the very-low-calorie diet, which would produce it with or without the injections.

This is a rare and useful thing to be able to say, because it is the opposite of the usual problem. Most claims in this category are unproven — nobody looked. This one was looked at repeatedly, by different groups, with the appropriate design, and it did not hold up. "Unproven" and "tested and failed" are very different epistemic positions, and a product still being sold in the second category tells you something about the seller.

If weight loss is the actual goal, the compounds with randomized evidence behind them are a different class entirely — see peptide injections for weight loss, peptides for fat loss and peptides for weight loss and muscle gain.

Why a Disproven Claim Keeps Selling

It is worth understanding the mechanics, because the same structure supports several other products in this category.

The hCG diet pairs the injections with a very-low-calorie diet — historically around 500 calories a day. Anyone eating at that level loses weight rapidly, and does so whether the syringe contains hCG or saline, which is precisely what the placebo arms of those trials demonstrated. The protocol therefore produces a dramatic, visible result that the customer attributes to the injection, because the injection is the part that felt like treatment.

That is a self-reinforcing loop no amount of trial evidence dislodges: the product appears to work, every time, for reasons that have nothing to do with the product. It is the cleanest example in this category of why personal experience and testimonials cannot settle a question that a placebo-controlled design can, and it is the same reason we do not publish before-and-after photographs as evidence — see BPC-157 before and after for how we treat that class of claim generally.

If weight loss is the goal, the honest comparison is against compounds that beat placebo in randomized trials rather than against a diet with a syringe attached. Those exist now, and they are covered on best semaglutide providers, best tirzepatide providers and best weight loss peptides for women. Be aware the advertised figures in that market have their own problem — SkinnyRx advertises "As low as $199/mo" when the rate you can stop paying after one month is $349, and Care Bare Rx names four GLP-1 products while publishing a price for none of them. HealthRX publishes the whole ladder with prepay marked optional, which is what the fair version looks like.

The Regulatory Position Is Not What Most Pages Say

This is the detail that catches people out, and it is worth getting right because it changed.

On March 23, 2020, a provision of the Biologics Price Competition and Innovation Act took effect: approved marketing applications for certain biological products transitioned to being regulated as licensed biologics under the Public Health Service Act. hCG was among the substances affected. The consequence that matters here is that transitioning biological products became ineligible for the compounding exemptions under sections 503A and 503B of the FD&C Act⁹.

In plain terms: hCG's position with respect to compounding pharmacies is not the same as it was before 2020, and it is not the same as an ordinary small-molecule drug. A page that describes compounded hCG as routinely available under the usual compounding rules is describing the situation before that transition.

We track this kind of thing against the primary record rather than against what sellers say about it — see the peptide FDA status tracker and what is the 503A bulks list, which explains why a compound's presence on a menu is not evidence of its regulatory standing. For the general question of what unapproved status means for a buyer, see are peptides legal.

Anti-Doping

Straightforward and worth stating: hCG is prohibited for male athletes under the World Anti-Doping Code, and its use as a masking or restart agent alongside androgens is precisely why. A fertility rationale is not an exemption. Check the current status with our WADA prohibited-status checker and see the 2026 Prohibited List for peptides.

Bottom Line

hCG is a genuine medicine with genuine uses, and it is worth separating them cleanly.

Real: gonadotropin therapy in male hypogonadotropic hypogonadism has documented benefits for spermatogenesis and fertility¹², and hCG given alongside testosterone replacement preserved spermatogenesis in men on TRT⁴. If you are starting testosterone and may want children, this is a conversation to have with a prescriber before the first injection, not after — the suppression is the expected consequence, not a rare one³.

Dead: the weight-loss claim. Randomized, placebo-controlled trials tested it repeatedly and it did not survive⁵⁶⁷⁸. That is a firmer negative than almost anything else on this site, because the studies exist rather than being absent.

Changed: the regulatory position, since the March 2020 biologics transition removed transitioning products from the compounding exemptions⁹.

For how we grade every compound against human evidence rather than mechanism, start at what are peptides good for, the rankings index, or the research library. And if a seller is offering hCG for weight loss, treat that as information about the seller — the checks are in peptide vendor red flags.